Sector Chart BioCryst Pharmaceuticals, Inc.
Stocks
BCRX
US09058V1035
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 10.09 USD | -0.79% |
|
+2.23% | +29.36% |
| 08-25 | BioCryst Pharmaceuticals Announces Approval Of ORLADEYO For Pediatric HAE Patients In Japan | CI |
| 08-25 | BioCryst Pharmaceuticals Gets Japan Approval for Orladeyo in Young Children | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.6B | - | - | - | ||
| 68.87B | |||||
| 65.29B | |||||
| 27.65B | - | ||||
| 25.77B | |||||
| 26.08B | - |
Select your edition
All financial news and data tailored to specific country editions
